Evidence map›Paper›PMID 34981491›Full record

ReviewAdvances in experimental medicine and biology2021

A Review of Glycyrrhiza glabra (Licorice) Effects on Metabolic Syndrome.

Fatemeh Jafari, Mohsen Jafari, Ali Tafazoli Moghadam, Seyed Ahmad Emami, Tannaz Jamialahmadi, Amir Hooshang Mohammadpour, Amirhossein Sahebkar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review on the Diverse Biological Effects of Glabridin.Drug design, development and therapy · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Fatemeh JafariSchool of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohsen JafariDepartment of Education, Neyshabur, Iran.
Ali Tafazoli MoghadamDepartment of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Seyed Ahmad EmamiDepartment of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. emami@mums.ac.ir.
Tannaz JamialahmadiDepartment of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran.
Amir Hooshang MohammadpourPharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. mohamadpoora@mums.ac.ir.
Amirhossein SahebkarApplied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.
Mashhad University of Medical Sciences · IRIslamic Azad University Quchan · IRShahid Beheshti University of Medical Sciences · IRUniversity of Neyshabur · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome is a pathological condition characterized by diabetes with insulin resistance, abdominal obesity, dyslipidemia, and hypertension. A wide body of research is emerging on Glycyrrhiza glabra L. (licorice) as a traditional herb with various therapeutic effects. Animal and human studies have indicated that licorice affects blood glucose, blood lipid profile, and blood pressure. Licorice seems to be effective in hyperglycemia and dyslipidemia; however, it can increase blood pressure. In this study, we intend to explain its role in regard with metabolic syndrome.

Indexed as

GlycyrrhizaMetabolic SyndromeTriterpenesAnimalsBlood GlucoseHumansPlant ExtractsBlood GlucosePlant ExtractsTriterpenesFabaceaeGlycyrrhiza glabraHyperglycemiaHyperlipidemiaHypertensionLicoriceMetabolic syndrome

Identifiers

PMID34981491
OpenAlexW4205711740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.